Xcorporeal Company Description
Xcorporeal (formerly CT Holdings Enterprises) is a medical device company engaged in the development of artificial kidneys and related products. Its prototype wearable artificial kidney is designed to provide ongoing dialysis, and an increasingly normal lifestyle, for its users. Xcorporeal also has home and hospital devices in development. Although focused on kidney replacement products, the company is also exploring applications for its technology to treat congestive heart failure. Xcorporeal was established in 2006; venture capital firm CT Holdings Enterprises acquired the company in a reverse merger the following year. Chairman Terren Peizer owns a majority stake in the company.
View the Comprehensive Company Description for Xcorporeal
The Company Description provides a historical perspective of Xcorporeal's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Xcorporeal's evolution in the marketplace.
